PACB
Pacific Biosciences of California
2.30$
+1.3%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 49.7% | 55.8% | 64.1% | 60.1% | 65.1% | 61.9% | 62.3% | 58.9% | 82.4% | 70.6% | 68.8% | 61.0% | 68.5% | 53.7% | 52.0% | 61.3% | 63.0% | 58.0% | 55.2% | 55.1% | 56.0% | 53.5% | 57.3% | 54.3% | 58.1% | 81.2% | 74.9% | 67.3% | 67.9% | 83.6% | 70.9% | 83.5% | 75.0% | 74.4% | 103.7% | 63.1% | 60.8% | 62.5% | 65.5% | 67.6% | 64.0% | |
| 50.3% | 44.2% | 35.9% | 39.9% | 34.9% | 38.1% | 37.7% | 41.1% | 17.6% | 29.4% | 31.2% | 39.0% | 31.5% | 46.3% | 48.0% | 38.7% | 37.0% | 42.0% | 44.8% | 44.9% | 44.0% | 46.5% | 42.7% | 45.7% | 41.9% | 18.8% | 25.1% | 32.7% | 32.1% | 16.4% | 29.1% | 16.5% | 25.0% | 25.6% | -3.7% | 36.9% | 39.2% | 37.5% | 34.5% | 32.4% | 36.0% | |
| 69.6% | 63.2% | 68.1% | 84.1% | 67.3% | 62.7% | 84.2% | 72.6% | 79.1% | 83.3% | 94.3% | 60.6% | 68.3% | 51.1% | 97.8% | 87.9% | 86.3% | 64.2% | 70.9% | 72.7% | 78.8% | 118.2% | 159.6% | 142.0% | 145.7% | 155.8% | 125.8% | 97.1% | 85.3% | 76.3% | 112.0% | 106.9% | 63.8% | 70.0% | 78.2% | 56.7% | 59.4% | 51.2% | 52.7% | 59.0% | 55.5% | |
| 47.4% | 50.5% | 61.3% | 77.2% | 59.3% | 57.7% | 77.1% | 69.3% | 74.4% | 103.0% | 120.3% | 77.5% | 91.6% | 59.3% | 159.9% | 88.6% | 77.4% | 66.2% | 269.5% | 94.9% | 90.6% | 103.6% | 116.8% | 110.7% | 113.9% | 164.5% | 133.9% | 89.4% | 78.0% | 78.8% | 112.7% | 127.4% | 109.5% | 106.2% | 108.1% | 91.0% | 80.9% | 76.3% | 83.8% | 85.6% | 81.4% | |
| 116.9% | 113.7% | 129.4% | 161.4% | 126.5% | 120.4% | 161.4% | 141.8% | 153.4% | 186.3% | 214.6% | 138.1% | 159.8% | 110.5% | 257.7% | 176.5% | 163.7% | 130.4% | 161.0% | 167.7% | 257.5% | 226.1% | 276.4% | 237.3% | 272.9% | 337.2% | 259.7% | 186.5% | 180.3% | 166.4% | 238.7% | 504.8% | 185.4% | 415.8% | 1,150.8% | 149.7% | 140.2% | 129.8% | 136.5% | 146.8% | 138.0% | |
| -66.6% | -69.5% | -93.5% | -121.5% | -91.6% | -82.3% | -123.7% | -100.8% | -135.8% | -156.8% | -183.5% | -99.0% | -128.3% | -64.1% | -209.7% | -137.8% | -126.7% | -88.4% | -116.3% | -122.7% | -213.5% | -179.6% | -233.7% | -191.6% | -230.9% | -318.4% | -234.6% | -153.8% | -148.1% | -150.0% | -209.6% | -488.3% | -160.3% | -390.1% | -1,154.5% | -112.8% | -101.0% | -92.3% | -102.0% | -114.4% | -102.1% | |
| 3.3% | 3.3% | 3.4% | 4.1% | 2.7% | 2.5% | 3.0% | 2.8% | 3.4% | 3.2% | 3.8% | 2.6% | 3.0% | 2.4% | 1.7% | 0.0% | 0.0% | 2.0% | 6.2% | 11.7% | 10.5% | 9.7% | 11.1% | 10.4% | 11.3% | 13.3% | 9.3% | 7.5% | 6.4% | 6.1% | 9.2% | 9.8% | 8.9% | 7.0% | 4.7% | 4.4% | 4.5% | 3.9% | 4.7% | 5.4% | 4.6% | |
| -69.6% | -74.0% | -95.8% | -127.2% | -93.5% | -83.3% | -124.9% | -104.5% | -137.9% | -157.7% | -184.6% | -99.9% | -132.9% | -0.3% | 8.1% | -135.2% | -124.2% | 276.1% | -301.5% | -133.9% | -224.4% | -189.2% | -245.7% | -201.3% | -238.2% | -308.5% | -226.3% | -146.8% | -139.3% | -141.8% | -201.4% | -481.3% | -151.9% | 6.9% | -1,147.6% | -105.4% | -97.9% | -90.0% | -21.8% | -114.6% | -82.0% | |
| 3.5% | 2.0% | 4.4% | 2.5% | 3.5% | -3.2% | 4.8% | 1.9% | -5.3% | -3.6% | 6.5% | 4.4% | 1.5% | -4.8% | -11.9% | -10.7% | -9.7% | -5.3% | -1.9% | 4.4% | -271.8% | 3.3% | 8.8% | -0.9% | 20.5% | -16.6% | -17.7% | 3.3% | -19.2% | -1.2% | 30.8% | – | -151.9% | 0.8% | -0.8% | 0.1% | 1.0% | 0.5% | 0.5% | 0.1% | 0.5% | |
| -69.6% | -74.0% | -95.8% | -127.2% | -93.5% | -83.3% | -124.9% | -104.5% | -137.9% | -157.7% | -184.6% | -99.9% | -132.9% | -0.3% | 8.1% | -135.2% | -124.2% | 276.1% | -301.5% | -133.9% | 47.4% | -192.5% | -245.7% | -201.3% | -238.2% | -308.5% | -226.3% | -146.8% | -120.1% | -140.5% | -201.4% | -481.3% | -151.9% | 6.0% | -1,146.8% | -105.4% | -98.9% | -90.4% | -22.3% | -114.7% | -82.5% | |
| -62.4% | -66.6% | -81.0% | -113.2% | -83.2% | -73.5% | -112.6% | -93.3% | -124.5% | -145.4% | -165.9% | -87.4% | -118.2% | 11.1% | 25.0% | -121.9% | -112.1% | 284.8% | -287.4% | -114.4% | -206.5% | -168.2% | -222.4% | -179.3% | -213.5% | -276.9% | -205.3% | -129.1% | -123.1% | -105.1% | -161.3% | -431.8% | -102.8% | 41.8% | -139.6% | -89.5% | -81.9% | -75.7% | -15.5% | -97.6% | -68.5% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.